Kenvue Inc.

KVUE 10-Q · Q1 2026
API behind this page

KVUE Q1 2026 request

Playground key active
Request URL /api/financials?ticker=KVUE&year=2026&quarter=1
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 3,909 3,741 +4.5%
Show Business Segments breakouts
Essential Health 1,151 1,097 +4.9%
Self Care 1,699 1,667 +1.9%
Skin Health and Beauty 1,059 977 +8.4%
Cost of Revenue 1,607 1,573 +2.2%
Show Counterparty Name breakouts
Johnson & Johnson 29 47 -38.3%
Show Restructuring Plan breakouts
2026 Restructuring Initiative 5 — —
Gross Profit 2,302 2,168 +6.2%
Selling, General & Administrative 1,453 1,537 -5.5%
Show Restructuring Plan breakouts
2026 Restructuring Initiative 2 — —
Restructuring Charges 71 60 +18.3%
Show Restructuring Plan breakouts
2026 Restructuring Initiative 71 — —
Other Operating Income Expense Net 11 13 -15.4%
Operating Income 767 558 +37.5%
Interest Income Expense Nonoperating Net 95 94 +1.1%
Income Before Taxes 672 458 +46.7%
Income Tax Expense (Benefit) 198 136 +45.6%
Net Income 474 322 +47.2%
Show Equity Components breakouts
Retained Earnings 474 322 +47.2%
Show Related Party Transaction breakouts
Net Economic Benefit Arrangements · Parent 5 8 -37.5%
EPS (Basic) 0.25 0.17 +47.1%
EPS (Diluted) 0.25 0.17 +47.1%
Wtd Avg Shares (Basic) 1,918 1,914 +0.2%
Wtd Avg Shares (Diluted) 1,922 1,925 -0.2%
Research & Development 84 99 -15.2%
Comprehensive Income 227 769 -70.5%
Other Comprehensive Income -247 447 -155.3%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 1 -3 +133.3%
Accumulated Other Comprehensive Income -247 447 -155.3%
Accumulated Translation Adjustment -232 452 -151.3%
Gain on Derivatives and Hedges -16 -2 -700.0%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 1,075 1,057 +1.7%
Accounts Receivable 2,501 2,312 +8.2%
Inventory 1,674 — —
Prepaid Expenses & Other Current Assets 410 — —
Other Assets Current 135 156 -13.5%
Total Current Assets 5,795 — —
Non-Current Assets
Property, Plant & Equipment 2,208 — —
Goodwill 9,376 9,136 +2.6%
Show Business Segments breakouts
Essential Health 1,670 1,626 +2.7%
Self Care 5,476 5,270 +3.9%
Skin Health and Beauty 2,230 2,240 -0.4%
Deferred Tax Assets 232 — —
Other Non-Current Assets 703 — —
Total Assets 26,854 — —
Show Counterparty Name breakouts
Johnson & Johnson 149 — —
Intangible Assets 3,673 3,802 -3.4%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 851 871 -2.3%
Other Intangible Assets 555 580 -4.3%
Patents and trademarks 2,267 2,351 -3.6%
Other Assets
Intangible Assets Net Excluding Goodwill 8,540 8,586 -0.5%
Show Indefinite Lived Intangible Assets By Major Class breakouts
Other Intangible Assets 62 60 +3.3%
Trademarks 4,805 4,724 +1.7%
Current Liabilities
Debt Current 1,589 2,429 -34.6%
Accounts Payable 2,533 — —
Show Related Party Transaction breakouts
Net Economic Benefit Arrangements · Parent 55 — —
Accrued Liabilities 901 — —
Accrued Rebates Returns And Promotions Current 777 — —
Accrued Income Taxes Current 96 154 -37.7%
Total Current Liabilities 5,896 — —
Commercial Paper 1,586 1,680 -5.6%
Non-Current Liabilities
Deferred Tax Liabilities 2,354 2,320 +1.5%
Employee Related Liabilities Current And Noncurrent 345 350 -1.4%
Other Non-Current Liabilities 579 — —
Total Liabilities 16,246 — —
Show Counterparty Name breakouts
Johnson & Johnson 291 — —
Operating Lease Liabilities 99 76 +30.3%
Accrued Income Taxes Noncurrent 241 192 +25.5%
Other Liabilities
Long Term Debt And Lease Obligation Excluding Current Maturities 7,072 6,309 +12.1%
Stockholders' Equity
Common Stock 19 19 0.0%
Additional Paid-In Capital 16,362 16,201 +1.0%
Treasury Stock Common Value -439 -305 -43.9%
Retained Earnings -128 -163 +21.5%
Accumulated Other Comprehensive Income -5,206 -5,699 +8.7%
Total Stockholders' Equity 10,608 10,053 +5.5%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -124 -133 +6.8%
Accumulated Other Comprehensive Income -5,206 -5,699 +8.7%
Accumulated Translation Adjustment -5,094 -5,588 +8.8%
Additional Paid In Capital 16,362 16,201 +1.0%
Common Stock 19 19 0.0%
Gain on Derivatives and Hedges 12 22 -45.5%
Retained Earnings -128 -163 +21.5%
Treasury Stock Common -439 -305 -43.9%
Total Liabilities & Equity 26,854 26,257 +2.3%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Depreciation & Amortization 143 136 +5.1%
Show Business Segments breakouts
Essential Health 60 58 +3.4%
Self Care 53 49 +8.2%
Skin Health and Beauty 30 29 +3.4%
Stock-Based Compensation 29 44 -34.1%
Deferred Income Taxes 28 -13 +315.4%
Other Non-Cash Items 18 16 +12.5%
Change in Accounts Receivable -136 -99 -37.4%
Change in Inventory -19 -66 +71.2%
Increase Decrease In Other Operating Assets -16 59 -127.1%
Increase Decrease In Accounts Payable And Accrued Liabilities -77 -14 -450.0%
Increase Decrease In Employee Related Liabilities 5 3 +66.7%
Increase Decrease In Accrued Taxes Payable 33 62 -46.8%
Increase Decrease In Other Operating Liabilities 7 -22 +131.8%
Net Cash from Operations 489 428 +14.3%
Investing Activities
Capital Expenditures -139 -179 +22.3%
Other Investing Activities -28 12 -333.3%
Net Cash from Investing -167 -167 0.0%
Financing Activities
Proceeds From Repayments Of Commercial Paper 870 868 +0.2%
Repayments Of Senior Debt -750 -750 0.0%
Payments Of Dividends -398 -392 -1.5%
Proceeds From Payments For Other Financing Activities -17 27 -163.0%
Net Cash from Financing -295 -310 +4.8%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -14 36 -138.9%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,075 1,057 +1.7%
Net Change in Cash 13 -13 +200.0%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key